Wuxi AppTec and Wuxi Biologics shares tumbled in Hong Kong after the US House of Representatives approved a bill that would restrict business with certain targeted Chinese biotech companies ...
WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in ...
Technologycategory US Senate bill targeting China's BGI, WuXi AppTec moves forward March 7, 2024 Technologycategory U.S. Senate committee approves bill that could restrict Chinese biotech March 6 ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in ...
The Biotechnology Innovation Organization (BIO) has said it is parting company with Wuxi AppTec, while voicing support for US legislation that would block Chinese biotechs from federal funding and ...
(Bloomberg) -- WuXi AppTec Co. generated 65% of its 2023 sales from the US, revenue that’s under threat by American political efforts to cut ties with Chinese biotechnology companies. The US ...
SHANGHAI, Sept. 1, 2024 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science ...